Six patients had moderate (n = 2, WHO score 4–6) or severe COVID-19 (n = 4, WHO score 7–10) requiring hospitalization and treatment with oxygen therapy (n = 5), corticosteroids (n = 5), and IL-6 monoclonal antibodies (n = 3). This evidence concerns the gene IL6 and COVID-19.